GlassScriptPhysician profile
David Miguel Hinkle
NPI 1760477624
$3,109.42
in general payments reported to CMS, 2019-2025
19 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $68.75 · 2021: $299 · 2022: $41.10 · 2023: $1,113 · 2024: $211 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $700.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,045.95 | 2022-2025 | Stellaris, Lotemax, Vyzulta |
| Alcon Vision LLC | $230.06 | 2020-2025 | Ngenuity, Argos, Clareon |
| Abbvie INC. | $161.05 | 2023-2025 | |
| Beaver-Visitec International, INC. | $136.37 | 2021 | |
| Ani Pharmaceuticals, INC. | $118.70 | 2025 | Purified Cortrophin Gel, Iluvien, Yutiq |
| Sun Pharmaceutical Industries INC. | $59.40 | 2024 | |
| Biotissue Holdings INC. | $51.46 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.67 | 2021 | |
| Optos, INC. | $33.60 | 2021 | |
| Spark Therapeutics, INC. | $32.38 | 2021 | |
| Dompe US, INC. | $32.17 | 2025 | Oxervate |
| Regeneron Healthcare Solutions, INC. | $24.15 | 2025 | Eylea Hd |
| Sight Sciences, INC. | $23.82 | 2023 | Omni Surgical System |
| Dutch Ophthalmic, USA | $22.95 | 2024 | Tissueblue, Eva, Combined Machine |
| Carl Zeiss Meditec USA, INC. | $22.84 | 2024 | Quatera 700 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $19.26 | 2025 | Dextenza |
| Glaukos Corporation | $17.93 | 2023 | |
| Aerie Pharmaceuticals, INC. | $17.71 | 2021 | |
| Allergan, INC. | $16.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.